EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Let-7a and miR-34a Interplay Potent Suppressive Roles in Hepatocellular Carcinoma via Co-Targeting FNDC3B, IGF2 and SOX4

Bangly Soliman, Ahmed Fawzy Ibrahim, Ahmed Salem, Mohamed Ghazy, Mahmoud T Abo-Elfadl iD, Mahmoud ElHefnawi iD, Mario Flores iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27041714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Bangly Soliman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Science, Ain Shams University, Cairo 1156, Egypt. Hauptthemen laut MEDLINE: MicroRNAs, Liver Neoplasms, Carcinoma, Hepatocellular, SOXC Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Scientific Research Technology PRISM program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Both let-7a and miR-34a have been repeatedly studied as pivotal suppressors for Hepatocellular carcinoma; however, their combined regulations remain to be fully elucidated. In the present study, we performed a comprehensive in silico analysis for let-7a and miR-34a using a wealth of updated tools: miRWalk, Genetrail and miRnet. In addition, our study is the first to quantify both miRs and their three predicted yet not experimentally validated oncogenic targets: FNDC3B, IGF2 and SOX4. This was assessed in HepG2 cell model following treatment by PEGP-vector expressing the miRs by MTT assay, florescence microscopy, qPCR and immune-florescence. Our bioinformatics analysis revealed a pool of common predicted hepatocarcinogenic targets shared by both let-7a and miR-34a. Importantly, three targets were identified as co-regulated through multiple canonical binding sites for each miR, and these had not been experimentally validated before. Furthermore, functional enrichment of these putative targets demonstrated their significant involvement in major and emerging HCC hallmarks, such as reprogramming of energy metabolism and evading immune destruction. These findings support our concept of simultaneous co-regulation of these oncogenes through the signaling networks and GO terms associated with both miRs. Consistently, our experimental results verified the significant overexpression of both miRs in HepG2 cells, leading to reduced tumor cell proliferation and decreased levels of the three oncogenic transcripts. Interestingly, miR-34a exhibited a superior suppression effect, reaching 38.7%, and SOX4 was identified as the most significantly downregulated target at both transcriptional and translational levels. Our findings provide new insights into the interconnected anti-HCC effects of let-7a and miR-34a and highlight the potential of applying their combined use to achieve the best therapeutic outcomes for this invasive tumor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsLiver NeoplasmsCarcinoma, HepatocellularSOXC Transcription FactorsInsulin-Like Growth Factor IIFibronectinsHumansGene Expression Regulation, NeoplasticHep G2 CellsCell Proliferation

Stichwörter der Autor:innen

combined regulatorsemerging HCC hallmarkshepatocellular carcinomain silico analysesin vitro verificationmajor HCC hallmarkssilencer miRNAs

Substanzen

MicroRNAsSOXC Transcription FactorsSOX4 protein, humanMIRN34 microRNA, humanInsulin-Like Growth Factor IImirnlet7 microRNA, humanIGF2 protein, humanFibronectins

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Science, Ain Shams University, Cairo 1156, Egypt.
  • Biomedical Informatics and Chemo-Informatics Group, Informatics and Systems Department, National Research Centre, Cairo 12622, Egypt.
  • Life Science and IVD Department, Attana AB, SE-11419 Stockholm, Sweden.
  • Biotechnology Program, Basic and Applied Science, Egypt-Japan University of Science and Technology (E-Just), New Borg El-Arab 21934, Egypt.
  • Biochemistry Department, Biotechnology Research Institute, National Research Centre, Cairo 12622, Egypt.
  • Cancer Biology and Genetics Laboratory, Centre of Excellence for Advanced Sciences, National Research Centre, Cairo 12622, Egypt.

ORCID-Profile: Mahmoud T Abo-Elfadl, Mahmoud ElHefnawi, Mario Flores

Förderung

  • Academy of Scientific Research Technology PRISM program

Zitieren

APA

Soliman, B., Ibrahim, A. F., Salem, A., Ghazy, M., Abo-Elfadl, M. T., ElHefnawi, M., & Flores, M. (2026). Let-7a and miR-34a Interplay Potent Suppressive Roles in Hepatocellular Carcinoma via Co-Targeting FNDC3B, IGF2 and SOX4. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041714

Vancouver

Soliman B, Ibrahim AF, Salem A, Ghazy M, Abo-Elfadl MT, ElHefnawi M, et al. Let-7a and miR-34a Interplay Potent Suppressive Roles in Hepatocellular Carcinoma via Co-Targeting FNDC3B, IGF2 and SOX4. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041714

BibTeX
@article{Soliman2026,
  author = {Soliman, Bangly and Ibrahim, Ahmed Fawzy and Salem, Ahmed and Ghazy, Mohamed and Abo-Elfadl, Mahmoud T and ElHefnawi, Mahmoud and Flores, Mario},
  title = {Let-7a and miR-34a Interplay Potent Suppressive Roles in Hepatocellular Carcinoma via Co-Targeting FNDC3B, IGF2 and SOX4},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27041714}
}
Kostenlos starten →